Skip to content
Drug recall · FDA · Published February 2, 2018

Aurobindo Pharma Ltd. recalls Metformin Hydrochloride Tablets, USP 1000 mg, 500-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc.

Aurobindo Pharma recalls Metformin Hydrochloride 1000mg tablets due to foreign tablet presence. Affected lots manufactured for Aurobindo Pharma USA, Inc. in Dayton, NJ. No remedy specified in recall notice.

🇺🇸 FDA recall #D-0427-2018DrugAurobindo Pharma ›
Take action

Contact the company & request your remedy

Recalling firmAurobindo Pharma Ltd.279 Princeton Hightstown Rd, N/A · East Windsor, NJ 08520-1401
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

Aurobindo Pharma is recalling Metformin Hydrochloride Tablets (1000mg, 50-count bottles) because foreign tablets were found in some batches. This could lead to incorrect dosing if taken without proper identification. Read more at govinfonow.com/recall/40893-aurobindo-pharma-metformin-tablets-recall-foreign-tablet-hazard.

Source Summary by GovInfoNow · govinfonow.com/recall/40893-aurobindo-pharma-metformin-tablets-recall-foreign-tablet-hazard · Updated October 7, 2026 · FDA enforcement record: FDA #D-0427-2018

Cite this page

“Aurobindo Pharma Metformin Tablets Recall: Foreign Tablet Hazard.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/40893-aurobindo-pharma-metformin-tablets-recall-foreign-tablet-hazard. Based on FDA recall #D-0427-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0427-2018%22&limit=1).

Why it’s dangerous

Foreign tablets were found in some batches of Metformin Hydrochloride 1000mg tablets. This could cause incorrect dosing if the foreign tablets are taken with the intended medication, potentially leading to overdose or underdose.

Who’s affected

Prescription drug users who purchased Metformin Hydrochloride Tablets 1000mg, 500-count bottles from Aurobindo Pharma USA, Inc. in Dayton, NJ. Most at risk are patients taking diabetes medication who may accidentally take extra tablets.

How to tell if you have this one

Check for the lot number MTSC17145-A on the bottle. The product was manufactured for Aurobindo Pharma USA, Inc. in Dayton, NJ, with an expiration date of July 2021.

  • Brand
    Aurobindo Pharma
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the lot number MTSC17145-A on the bottle label to confirm if it's affected.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The recall states foreign tablets were found in some batches, but no remedy is specified. Affected products should be checked for the lot number MTSC17145-A.

What should I do if I have this product?

The recall notice does not specify a remedy. Check the lot number on the bottle to see if it's affected.

How can I confirm if my product is recalled?

Check for the lot number MTSC17145-A on the bottle. The product was manufactured for Aurobindo Pharma USA, Inc. in Dayton, NJ with an expiration date of July 2021.

Take action

Contact Aurobindo Pharma

We’ve drafted a message you can send Aurobindo Pharma to request your refund or repair — edit it as you like.

Subject: Recall D-0427-2018 — Aurobindo Pharma Aurobindo Pharma

Hello,

I own a Aurobindo Pharma that is covered by recall D-0427-2018 from Aurobindo Pharma.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0427-2018 (February 2, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0427-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA